These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 21491608)
1. Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy. Fechete R; Heinzel A; Perco P; Mönks K; Söllner J; Stelzer G; Eder S; Lancet D; Oberbauer R; Mayer G; Mayer B Proteomics Clin Appl; 2011 Jun; 5(5-6):354-66. PubMed ID: 21491608 [TBL] [Abstract][Full Text] [Related]
2. Systems biology: building a useful model from multiple markers and profiles. Mayer P; Mayer B; Mayer G Nephrol Dial Transplant; 2012 Nov; 27(11):3995-4002. PubMed ID: 23144070 [TBL] [Abstract][Full Text] [Related]
4. [Novel biomarkers for diabetic nephropathy]. Araki S Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493 [TBL] [Abstract][Full Text] [Related]
5. Proteomics in gerontology: current applications and future aspects--a mini-review. Schiffer E; Mischak H; Zimmerli LU Gerontology; 2009; 55(2):123-37. PubMed ID: 19136815 [TBL] [Abstract][Full Text] [Related]
6. New insights into the use of biomarkers of diabetic nephropathy. Jha JC; Jandeleit-Dahm KA; Cooper ME Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461 [TBL] [Abstract][Full Text] [Related]
7. Insights into predicting diabetic nephropathy using urinary biomarkers. Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766 [TBL] [Abstract][Full Text] [Related]
8. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM; Mauer M; Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy. Zhang Y; Zhang Q Biochem Biophys Res Commun; 2009 May; 383(1):1-3. PubMed ID: 19303394 [TBL] [Abstract][Full Text] [Related]
11. Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis. Aschauer C; Perco P; Heinzel A; Sunzenauer J; Oberbauer R PLoS One; 2017; 12(1):e0169518. PubMed ID: 28060893 [TBL] [Abstract][Full Text] [Related]
12. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring. Rossing K Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525 [No Abstract] [Full Text] [Related]
13. Mechanisms of diabetic nephropathy--old buddies and newcomers part 2. Nawroth PP; Isermann B Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):667-72. PubMed ID: 20658437 [TBL] [Abstract][Full Text] [Related]
14. Early detection of endothelial dysfunction and early therapeutic correction effectively restore renal function in type 2 diabetic nephropathy. Futrakul N; Butthep P Ren Fail; 2005; 27(4):493-4. PubMed ID: 16060141 [No Abstract] [Full Text] [Related]
15. Diabetic nephropathy: important pathophysiologic mechanisms. Soldatos G; Cooper ME Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S75-9. PubMed ID: 18994672 [TBL] [Abstract][Full Text] [Related]
16. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462 [TBL] [Abstract][Full Text] [Related]
17. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics. Phan JH; Quo CF; Wang MD Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692 [TBL] [Abstract][Full Text] [Related]